Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis-Reference-Cited by-同舟云学术

Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis

Published:2016-10 Issue: Volume:299 Page:112-117
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Mañé-Martínez M.Alba,Olsson Bob,Bau Laura,Matas Elisabet,Cobo-Calvo Álvaro,Andreasson Ulf,Blennow Kaj,Romero-Pinel Lucia,Martínez-Yélamos Sergio,Zetterberg Henrik

Funder

Fundació Hospital Universitari de Tarragona Joan XXIII

Fundació Institut d'Investigació Biomèdica de Bellvitge

Publisher

Elsevier BV

Subject

Neurology (clinical),Neurology,Immunology,Immunology and Allergy

Reference28 articles.

1. Multiplexing and multivariate analysis in neurodegeneration;Andreasson;Methods,2012

2. Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis;Axelsson;J. Neurol.,2011

3. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis;Barkhof;Brain,1997

4. The distribution of tau in the mammalian central nervous system;Binder;J. Cell Biol.,1985

5. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease;Blennow;Nat. Rev. Neurol.,2010

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can Selected Parameters of Brain Injury Reflect Neuronal Damage in Smoldering Multiple Sclerosis?;Diagnostics;2024-09-09

2. Biomarkers Differentiating RRMS and SPMS in Multiple Sclerosis—A Systematic Review;Sclerosis;2024-07-31

3. A rapid review of differences in cerebrospinal neurofilament light levels in clinical subtypes of progressive multiple sclerosis;Frontiers in Neurology;2024-04-09

4. Baseline serum neurofilament light chain levels differentiate aggressive from benign forms of relapsing–remitting multiple sclerosis: a 20-year follow-up cohort;Journal of Neurology;2023-12-12

5. Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis;Multiple Sclerosis and Related Disorders;2023-12